Navigation Links
Stress-Reduction Therapy May Help Heart Disease Patients

By Steven Reinberg
HealthDay Reporter

MONDAY, Jan. 24 (HealthDay News) -- A stress management program based on cognitive behavioral therapy may reduce the risk of heart attack, stroke and death in patients with heart disease, Swedish researchers report.

About 30 percent of heart attacks may be linked to "psychosocial factors," including chronic stressors such as poverty or emotional problems, such as depression and hostility, the authors note in the Jan. 24 issue of the Archives of Internal Medicine.

"Psychological treatment appears to prevent recurrent [cardiac] events at least as effective as many of today's established pharmacological treatments," said lead researcher Dr. Mats Gulliksson, from the Family Medicine and Clinical Epidemiology Section at Uppsala University Hospital.

For the study, Gulliksson's group randomly assigned 362 men and women with heart disease to usual care and cognitive behavioral therapy or usual care with no therapy. Patients in therapy underwent 20 two-hour sessions over a year.

Usual care included medications to lower blood pressure and cholesterol or to prevent blood clots, Gulliksson said.

The premise of CBT is that by changing the way you think about something, you can help yourself feel or behave better. The study program included five key components with specific goals -- education, self-monitoring, skills training, cognitive restructuring and spiritual development -- and focused on stress management, specifically reducing the experience of daily stress, time urgency and hostility.

Over almost eight years of follow-up, the CBT group had 23 deaths, 69 cardiovascular events, and 41 heart attacks. However, among those who did not take part in therapy, 25 died, 77 had any type of cardiovascular event and 51 suffered heart attacks, the researchers found.

That works out to 41 percent fewer deaths and heart-related events and 45 percent fewer heart attacks among those in the CBT group, compared with patients who did not receive therapy, they add.

Those who went to the most therapy sessions had a further reduction in risk, the researchers note. "The higher the attendance rates, the lower the risk," Gulliksson said.

"The psychological treatment had a clear impact beyond the already known beneficial effects of conventional treatments to prevent recurrent events," Gulliksson said. "The effects were similar for men and women," he added.

Exactly how the stress management strategies protect the heart is a question for future research, he noted.

It's possible that the better outcomes relate to long-term participation (six to 12 months at least) in a group designed to alter behavior, the authors say. Perhaps by decreasing emotional and behavioral reactivity, people can alleviate some of the burden placed on the cardiovascular system, they add.

"The positive results suggest that cognitive behavioral therapy intervention based on stress management should be added to secondary prevention programs and offered to all coronary heart disease patients," Gulliksson said. The therapy is also inexpensive and without side effects, he added.

But at least one expert remained unconvinced that the health benefits noted in the study were related to the CBT therapy.

"We know from many trials that people in intervention trials tend to get better care," said Dr. Robert Myerburg, a professor of medicine and cardiology at the University of Miami Miller School of Medicine.

What isn't clear from the study is whether the therapy patients kept to their medication regimen more consistently than the non-therapy patients, he said. For example, the study authors don't show whether blood pressure and cholesterol were better controlled in the therapy group than in the non-therapy group, Myerburg said.

"The question is, is this a direct effect or a nonspecific effect of an intervention where we know that people tend to 'behave better' in terms of their outcomes and therapies?" he said.

Despite his skepticism, Myerburg doesn't see a downside if a patient wants to try cognitive behavioral therapy.

"What I say to patients, as with all these unproven therapies, is as long as they are not doing harm I have no objection," he said.

More information

For more information on cognitive behavioral therapy, visit the U.S. National Association of Cognitive-Behavioral Therapists.

SOURCES: Mats Gulliksson, M.D., Ph.D., Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology Section, Uppsala University Hospital, Uppsala, Sweden; Robert Myerburg, M.D., professor, medicine, cardiology, University of Miami Miller School of Medicine; Jan. 24, 2011, Archives of Internal Medicine

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. HIV-positive head and neck cancer patients benefit from radiation therapy
2. Therapy May Help Cut Incontinence After Prostate Surgery
3. Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear
4. VIB-K.U. Leuven scientists clear the way to alternative anti-angiogenic cancer therapy
5. Agenda set for upcoming global conference on stem cell therapy to be held Jan. 20-21, 2011
6. Common Sleep Apnea Therapy Relieves Fatigue: Study
7. Study shows that CPAP therapy reduces fatigue, increases energy in patients with sleep apnea
8. Penn researchers identify potential target for breast cancer therapy
9. Intensive chemotherapy can dramatically boost survival of older teenage leukemia patients
10. Speech, Swallowing Usually OK After Head & Neck Cancer Therapy
11. New combo lung cancer therapy improves survival over single-line treatment
Post Your Comments:
Related Image:
Stress-Reduction Therapy May Help Heart Disease Patients 
(Date:11/25/2015)... ... ... “While riding the bus, I saw a passenger in a wheelchair drenched from ... a convenient and comfortable way to protect them from bad weather, so I invented ... during cold or inclement weather. In doing so, it ensures that the user remains ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely combination ... in a way for homeless people to have a more dignified and comfortable ... initiative whereby they are repurposing plastic bags into sleeping mats for the homeless. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... focused on providing comprehensive solutions involving adult stem cell therapies to patients with ... deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required ...
(Date:11/24/2015)... ... 2015 , ... Genesis Chiropractic Software helps practice owners automate ... between the practice owner and the patient that automatically manages all five aspects ... Click here to learn more. , According to Dr. Brian ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
Breaking Medicine Technology: